Anthony Vendetti
Stock Analyst at Maxim Group
(1.71)
# 1,378
Out of 4,502 analysts
61
Total ratings
20.83%
Success rate
-4%
Average return
Main Sectors:
32 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RSLS ReShape Lifesciences | Downgrades: Hold | n/a | $0.21 | - | 2 | Jul 17, 2024 | |
| CELH Celsius Holdings | Maintains: Buy | $110 → $90 | $46.40 | +93.99% | 5 | Jun 18, 2024 | |
| ZIVO ZIVO Bioscience | Downgrades: Hold | n/a | $8.49 | - | 2 | Jun 4, 2024 | |
| SRTS Sensus Healthcare | Maintains: Buy | $7 → $10 | $6.34 | +57.73% | 4 | May 10, 2024 | |
| HAIN The Hain Celestial Group | Maintains: Buy | $18 → $15 | $7.44 | +101.61% | 4 | May 9, 2024 | |
| GHSI Guardion Health Sciences | Downgrades: Hold | n/a | $9.85 | - | 2 | Feb 2, 2024 | |
| MLEC Moolec Science | Initiates: Buy | $6 | $1.03 | +482.52% | 1 | Jan 30, 2024 | |
| MAMA Mama's Creations | Initiates: Buy | $10 | $7.52 | +32.98% | 1 | Dec 20, 2023 | |
| YTEN Yield10 Bioscience | Downgrades: Hold | n/a | $1.59 | - | 2 | Nov 16, 2023 | |
| RMTI Rockwell Medical | Initiates: Buy | $5 | $1.85 | +170.27% | 1 | Oct 5, 2023 | |
| YCBD cbdMD | Initiates: Buy | $3 | $0.60 | +398.92% | 1 | Oct 5, 2023 | |
| JYNT The Joint | Downgrades: Hold | n/a | $13.63 | - | 3 | Aug 11, 2023 | |
| MYO Myomo | Initiates: Buy | $2 | $4.86 | -58.85% | 1 | May 25, 2023 | |
| ICU SeaStar Medical Holding | Initiates: Buy | $125 | $7.89 | +1,484.28% | 1 | Apr 20, 2023 | |
| UGRO urban-gro | Maintains: Buy | $12 → $7 | $1.50 | +366.67% | 3 | Mar 31, 2023 | |
| CUTR Cutera | Downgrades: Hold | n/a | $1.40 | - | 2 | Mar 30, 2023 | |
| VKTX Viking Therapeutics | Maintains: Buy | $15 → $25 | $64.68 | -61.35% | 1 | Mar 29, 2023 | |
| LUXH LuxUrban Hotels | Maintains: Buy | $6 → $7 | $0.15 | +4,532.69% | 1 | Mar 29, 2023 | |
| BIOL BIOLASE | Maintains: Buy | $500 → $100 | $0.07 | +146,742.88% | 2 | Mar 29, 2023 | |
| VERO Venus Concept | Downgrades: Hold | n/a | $0.53 | - | 1 | Mar 28, 2023 | |
| EDBL Edible Garden AG | Maintains: Buy | $240 → $140 | $1.34 | +10,347.76% | 2 | Mar 23, 2023 | |
| DRMA Dermata Therapeutics | Maintains: Buy | $240 → $60 | $2.58 | +2,225.58% | 2 | Mar 23, 2023 | |
| HSDT Helius Medical Technologies | Initiates: Buy | $50 | $0.78 | +6,275.92% | 1 | Dec 20, 2022 | |
| BRFH Barfresh Food Group | Maintains: Buy | $13 → $5 | $3.50 | +42.86% | 2 | Nov 15, 2022 | |
| AEMD Aethlon Medical | Downgrades: Hold | n/a | $0.38 | - | 2 | Nov 15, 2022 | |
| REED Reed's | Downgrades: Hold | n/a | $1.48 | - | 1 | Nov 14, 2022 | |
| ICCM IceCure Medical | Initiates: Buy | $3 | $0.78 | +287.10% | 1 | Oct 25, 2022 | |
| PLSE Pulse Biosciences | Downgrades: Hold | n/a | $17.71 | - | 2 | Sep 21, 2022 | |
| ACON Aclarion | Initiates: Buy | $48 | $0.31 | +15,444.04% | 1 | Jul 6, 2022 | |
| APDN Applied DNA Sciences | Upgrades: Buy | $160 | $0.42 | +38,444.93% | 3 | Nov 22, 2019 | |
| BKYI BIO-key International | Maintains: Buy | $792 → $720 | $1.62 | +44,344.44% | 2 | Aug 16, 2018 | |
| FIZZ National Beverage | Maintains: Sell | n/a | $49.42 | - | 2 | Mar 9, 2018 |
ReShape Lifesciences
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.21
Upside: -
Celsius Holdings
Jun 18, 2024
Maintains: Buy
Price Target: $110 → $90
Current: $46.40
Upside: +93.99%
ZIVO Bioscience
Jun 4, 2024
Downgrades: Hold
Price Target: n/a
Current: $8.49
Upside: -
Sensus Healthcare
May 10, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $6.34
Upside: +57.73%
The Hain Celestial Group
May 9, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $7.44
Upside: +101.61%
Guardion Health Sciences
Feb 2, 2024
Downgrades: Hold
Price Target: n/a
Current: $9.85
Upside: -
Moolec Science
Jan 30, 2024
Initiates: Buy
Price Target: $6
Current: $1.03
Upside: +482.52%
Mama's Creations
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $7.52
Upside: +32.98%
Yield10 Bioscience
Nov 16, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.59
Upside: -
Rockwell Medical
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $1.85
Upside: +170.27%
cbdMD
Oct 5, 2023
Initiates: Buy
Price Target: $3
Current: $0.60
Upside: +398.92%
The Joint
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $13.63
Upside: -
Myomo
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $4.86
Upside: -58.85%
SeaStar Medical Holding
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $7.89
Upside: +1,484.28%
urban-gro
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $1.50
Upside: +366.67%
Cutera
Mar 30, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.40
Upside: -
Viking Therapeutics
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $64.68
Upside: -61.35%
LuxUrban Hotels
Mar 29, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $0.15
Upside: +4,532.69%
BIOLASE
Mar 29, 2023
Maintains: Buy
Price Target: $500 → $100
Current: $0.07
Upside: +146,742.88%
Venus Concept
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.53
Upside: -
Edible Garden AG
Mar 23, 2023
Maintains: Buy
Price Target: $240 → $140
Current: $1.34
Upside: +10,347.76%
Dermata Therapeutics
Mar 23, 2023
Maintains: Buy
Price Target: $240 → $60
Current: $2.58
Upside: +2,225.58%
Helius Medical Technologies
Dec 20, 2022
Initiates: Buy
Price Target: $50
Current: $0.78
Upside: +6,275.92%
Barfresh Food Group
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $3.50
Upside: +42.86%
Aethlon Medical
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.38
Upside: -
Reed's
Nov 14, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.48
Upside: -
IceCure Medical
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $0.78
Upside: +287.10%
Pulse Biosciences
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $17.71
Upside: -
Aclarion
Jul 6, 2022
Initiates: Buy
Price Target: $48
Current: $0.31
Upside: +15,444.04%
Applied DNA Sciences
Nov 22, 2019
Upgrades: Buy
Price Target: $160
Current: $0.42
Upside: +38,444.93%
BIO-key International
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $1.62
Upside: +44,344.44%
National Beverage
Mar 9, 2018
Maintains: Sell
Price Target: n/a
Current: $49.42
Upside: -